康希诺：ACYW135群脑膜炎球菌多糖结合疫苗适用人群年龄范围扩大

Core Viewpoint - The company, CanSino (688185.SH), announced an expansion of the age range for its ACYW135 group meningococcal polysaccharide conjugate vaccine, which is expected to positively impact its performance [1] Group 1 - The product's age range has been expanded from "3 months to 3 years (47 months) children" to "3 months to 6 years (83 months) children" [1] - This vaccine is the first quadrivalent conjugate meningococcal vaccine product in China [1] - The expansion of the applicable age group is anticipated to have a positive effect on the company's performance [1]